F Dx Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History

F Dx Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $3.54 Million - $6.16 Million	40,316 New	40,316 $1.15 Million
Q3 2019 Nov 07, 2019	SELL	$125.18 - $143.24 $207,423 - $237,348	-1,657 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$125.55 - $144.48 $25,361 - $29,184	202 Added 13.88%	1,657 $236,000
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $177,233 - $207,992	1,455 New	1,455 $208,000
Q4 2018 Feb 07, 2019	SELL	$115.94 - $166.74 $178,083 - $256,112	-1,536 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $19,482 - $21,848	121 Added 8.55%	1,536 $258,000
Q2 2018 Aug 08, 2018	BUY	$146.33 - $183.18 $207,056 - $259,199	1,415 New	1,415 $244,000

511

57.6M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.57B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.